Literature DB >> 928708

Juvenile ankylosing spondylitis.

P Kleinman, M Rivelis, R Schneider, J J Kaye.   

Abstract

The clinical histories and radiographs of 28 patients with ankylosing spondylitis were reviewed. Symptoms developed before the age of 17 in all cases. Juvenile ankylosing spondylitis affected youths in their early teens, who presented most commonly with appendicular joint complaints rather than low back pain. The disease was progressive, with the characteristic changes of ankylosing spondylitis eventually occurring in the spine and sacroiliac joints, frequently accompanied by widespread and severe changes in the appendolar joints. HLA B 27 antigen was present in 8 of the 9 patients tested. Thorough clinical, radiographic, and laboratory examination should prevent confusion with juvenile rheumatoid arthritis.

Entities:  

Mesh:

Year:  1977        PMID: 928708     DOI: 10.1148/125.3.775

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  HLA-B27 positive juvenile arthritis with cardiac involvement preceding sacroiliac joint changes.

Authors:  S J Lee; H Y Im; W C Schueller
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 2.  Spondyloarthropathy presenting at a young age: case report and review.

Authors:  Golda H Hartman; Deborah L Renaud; Murali Sundaram; Ann M Reed
Journal:  Skeletal Radiol       Date:  2006-05-20       Impact factor: 2.199

Review 3.  New advances in juvenile spondyloarthritis.

Authors:  Shirley M L Tse; Ronald M Laxer
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

4.  Late sequelae of juvenile rheumatoid arthritis of the hip: a follow-up study into adulthood.

Authors:  H B Patriquin; M Camerlain; A Trias
Journal:  Pediatr Radiol       Date:  1984

Review 5.  Juvenile spondyloarthropathies: clinical manifestations and medical imaging.

Authors:  E M Azouz; C M Duffy
Journal:  Skeletal Radiol       Date:  1995-08       Impact factor: 2.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.